NCT00145483View on ClinicalTrials.gov

Sildenafil For Meniere's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

163

Participants

Timeline

Start Date

June 18, 2002

Primary Completion Date

November 8, 2006

Study Completion Date

November 8, 2006

Conditions
Meniere's Disease
Interventions
DRUG

Sildenafil

Trial Locations (4)

Unknown

Pfizer Investigational Site, Bondi Junction

Pfizer Investigational Site, Brisbane

Pfizer Investigational Site, East Melbourne

Pfizer Investigational Site, Melbourne

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00145483 - Sildenafil For Meniere's Disease | Biotech Hunter | Biotech Hunter